反应详情

1,4-Dimethyl-3-(3-{7-[3-(morpholine-4-sulfonyl)-phenyl]-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino}-phenyl)-piperazin-2-one was prepared from 7-[3-(morpholine-4-sulfonyl)-phenyl]-pyrrolo[2,1-f][1,2,4]triazin-2-ol and 3-(3-amino-phenyl)-1,4-dimethyl-piperazin-2-one in an analogous manner to Example 1052a. Product isolated as a yellow foam (84 mg, 49%). LCMS (m/e) 562 (M+H); 1H-NMR (CDCl3, 400 MHz) δ 8.75 (s, 1H), 8.63 (d, 1H, J=7.5 Hz), 8.28 (s, 1H), 7.88-7.81 (m, 1H), 7.75-7.64 (m, 2H), 7.43-7.35 (m, 1H), 7.33 (s, 1H), 7.09 (d, 1H, J=7.6 Hz), 7.05 (d, 1H, J=4.8 Hz), 6.90 (s, 1H), 6.86 (d, 1H, J=4.8 Hz), 3.78-3.65 (m, 6H), 3.26-3.18 (m, 1H), 3.10-3.03 (m, 4H), 3.03-2.96 (m, 4H), 2.74-2.62 (m, 1H), 2.17 (s, 3H).